about
Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapyIn vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicideComparability and reproducibility of biomedical dataPre-existing adenovirus immunity modifies a complex mixed Th1 and Th2 cytokine response to an Ad5/HIV-1 vaccine candidate in humansImmune-correlates analysis of an HIV-1 vaccine efficacy trialDevelopment of an automated analysis system for data from flow cytometric intracellular cytokine staining assays from clinical vaccine trials.Statistical methods for analyzing tissue microarray data.Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials.Equivalence of ELISpot assays demonstrated between major HIV network laboratoriesComparing and combining data across multiple sources via integration of paired-sample data to correct for measurement error.Immune-correlates analysis of an HIV-1 vaccine efficacy trial reveals an association of nonspecific interferon-γ secretion with increased HIV-1 infection risk: a cohort-based modeling studyA trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers.HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trialHIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable.Vaccine-induced HIV-specific CD8+ T cells utilize preferential HLA alleles and target-specific regions of HIV-1.Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects.Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccineEffect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized TrialsThe sexually driven epidemic in youths in China's southwestern border region was caused by dynamic emerging multiple recombinant HIV-1 strainsDevelopment and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cellsRole of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.Use of placebos in Phase 1 preventive HIV vaccine clinical trialsExtended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study)New clinical trial designs for HIV vaccine evaluation.Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma.Predictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trials.Selection of HIV vaccine candidates for concurrent testing in an efficacy trial.Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects.Population pharmacokinetics analysis of VRC01, an HIV-1 broadly neutralizing monoclonal antibody, in healthy adults.A case for preART-adjusted endpoints in HIV therapeutic vaccine trials.A Systems Vaccinology Approach Reveals Temporal Transcriptomic Changes of Immune Responses to the Yellow Fever 17D Vaccine.Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults.Power/sample size calculations for assessing correlates of risk in clinical efficacy trials.Reply to Richie and Villasante.Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination.Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma.P16-19. Statistical design and analysis of the CAVD-VIMC Elispot transfer study 001.China and HIV Vaccine Research: An Old Country with a New CommitmentAnalysis of the Na,K-ATPase α- and β-subunit expression profiles of bladder cancer using tissue microarraysAntigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial
P50
Q28208220-2A300C12-4689-4F88-882E-4E7F902C5737Q28472968-85BD52D2-2594-4995-9ED2-C9AAD2768DFAQ28677246-A35CCB4C-339C-4562-A410-3FB5557CFA06Q28741103-3A209565-0ABD-4EE0-8DDA-6D72A644B9C6Q29617377-A517ED0D-AE69-40CD-B9D0-314F42D485C3Q31162124-54EB371A-6EFB-489E-BF76-D7CE968DDEF1Q33207692-C466792C-7925-4602-8746-2CB896BF83D5Q33256768-D92E804F-CE04-4F7E-BA37-166EA7075CB9Q33778327-F8124F28-B8AE-4BD1-B309-F3A0C8680814Q34327212-39B952E6-5375-44BA-9994-06A5FA89E3AAQ34450043-2CA0ABF4-A2FB-4EA7-B34F-D4A9CF686CD1Q34743297-9D707427-63B6-4472-B620-73CB7631E080Q35140001-095FA1D2-A0BF-4991-B284-D7CB8FA3799CQ35234257-F89B15B3-02D6-4345-9EC5-0830E56A9928Q35388181-B8E8BA38-7349-4ED8-BAC9-BDBE707DF90DQ35567414-F4797626-66D9-49CF-B0B2-3E992D97D0AAQ35640645-605CB647-F12B-4DB9-ABD9-564BFC6A3DD9Q35762443-3BD8769A-72C5-4949-BBAA-67AB44A1A748Q35809748-5171F6B6-3656-4929-BFD0-CDBFC8840C85Q35903806-94C29DE5-6CBF-42B7-B4D3-CE3CD11C0F8AQ35947958-9341903A-A854-407C-A35E-A855D9A3E284Q36011214-30999673-7489-406C-BCD7-C2E86B0020E4Q36376210-4E833808-1B72-4465-A4F1-3594411FF010Q37412300-4367DC06-9CD6-417E-8532-13EE011460D7Q38356065-2DA3665F-2B0C-4EE8-AE2C-EEABC59628D1Q38381606-F4D2E285-9D15-4F9A-9E13-340B611AC330Q38716886-88E4CD07-7E6E-4BE6-9749-FFEFE4AB7333Q38727815-CEA57885-17AC-40DC-AFF4-6BC0719C9DC7Q38736222-5B19A961-2B7D-4001-B14F-611EF627ED10Q38914357-65E73353-C4AE-40CA-994C-210BB1588B39Q40049495-59F387E7-0F25-4D7A-8348-F34B3AACB74BQ40114912-9B882DFE-E248-4E77-8FFE-4C8D1552F0F5Q40731419-2BFEDD96-DAA3-43AF-B156-EAC3864943ECQ42947858-DEAB66FE-F60F-49A6-A5CD-203E54BDB895Q43125298-D6A92945-5C9E-4111-B950-6E60952F10A7Q45955829-5A5198E4-6E17-4537-8663-25FAC2E6061AQ55690930-E89BC69A-5F5D-4EF0-AE77-7C83C15E52E5Q57262004-F3BE48E8-79C7-4CB4-A699-F0FCA88B4EBAQ57262009-1888921F-5715-49EE-8F77-3833B4E52FA8Q91360476-01D40825-56F9-4E34-B9AA-EE7F40B9B88C
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Yunda Huang
@ast
Yunda Huang
@en
Yunda Huang
@es
Yunda Huang
@sl
type
label
Yunda Huang
@ast
Yunda Huang
@en
Yunda Huang
@es
Yunda Huang
@sl
prefLabel
Yunda Huang
@ast
Yunda Huang
@en
Yunda Huang
@es
Yunda Huang
@sl
P106
P1153
7501575055
P21
P31
P496
0000-0003-1546-6172